Patents by Inventor Katherine Roby

Katherine Roby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lonidamine analogues for fertility management
    Patent number: 8377958
    Abstract: Fertility management can include: administering to the subject one or more doses of a compound according to Formula I so as to reduce fertility in the subject. Fertility management can also include administering an effective amount of the compound to: impair Sertoli cell function in a male subject; inhibit spermatogenesis in the subject; reduce testis weight in the subject; reduce ovary weight in a female subject; reduce serum progesterone in the female subject; impair ovarian follicle function in the female subject; causing reversible fertility in the subject. In order to return fertility, the method can include ceasing administration of the compound to the subject so as to return fertility in the subject. The compound can be administered for irreversibly sterilizing the subject.
    Type: Grant
    Filed: July 6, 2010
    Date of Patent: February 19, 2013
    Assignee: The University of Kansas
    Inventors: Ingrid Gunda Georg, Joseph S. Tash, Ramappa Chakrasali, Sudhakar Rao Jakkaraj, Katherine Roby
  • LONIDAMINE ANALOGUES FOR FERTILITY MANAGEMENT
    Publication number: 20110060003
    Abstract: Fertility management can include: administering to the subject one or more doses of a compound according to Formula I so as to reduce fertility in the subject. Fertility management can also include administering an effective amount of the compound to: impair Sertoli cell function in a male subject; inhibit spermatogenesis in the subject; reduce testis weight in the subject; reduce ovary weight in a female subject; reduce serum progesterone in the female subject; impair ovarian follicle function in the female subject; causing reversible fertility in the subject. In order to return fertility, the method can include ceasing administration of the compound to the subject so as to return fertility in the subject. The compound can be administered for irreversibly sterilizing the subject.
    Type: Application
    Filed: July 6, 2010
    Publication date: March 10, 2011
    Inventors: Ingrid Gunda Georg, Joseph S. Tash, Ramappa Chakrasali, Sudhakar Rao Jakkaraj, Katherine Roby
  • Production of terephthalic acid with excellent optical properties through the use of pure or nearly pure oxygen as the oxidant in p-xylene oxidation
    Patent number: 5696285
    Abstract: The production of terephthalic acid by the oxidation of p-xylene is carried out in such a manner that the oxygen concentration in the liquid phase is maximized through the use of pure or nearly pure oxygen, while simultaneously the hydrocarbon feed concentration is minimized through rapid dilution with the reactor contents.
    Type: Grant
    Filed: December 29, 1995
    Date of Patent: December 9, 1997
    Assignee: Praxair Technology, Inc.
    Inventor: Anne Katherine Roby